|
顯示項目 871661-871670 / 2348719 (共234872頁)
<< < 87162 87163 87164 87165 87166 87167 87168 87169 87170 87171 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-06-04T06:23:01Z |
Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation
|
Chen G.-J.;Lin S.-W.;Tsai I.-L.;Ching-Hua Kuo;Wang J.-T.;Hsieh S.-M.; Chen G.-J.; Lin S.-W.; Tsai I.-L.; CHING-HUA KUO; Wang J.-T.; Hsieh S.-M. |
| 臺大學術典藏 |
2022-09-07T06:39:12Z |
Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation
|
Chen G.-J.; SHU-WEN LIN; Tsai I.-L.; Kuo C.-H.; Wang J.-T.; Hsieh S.-M. |
| 國立臺灣大學 |
1986 |
Therapeutic Drug Monitoring of Valproic Acid by Gas-Liquid Chromatography
|
余秀瑛; Shen, Y. Z.; Yu, Hsiu-Ying; Shen, Y. Z. |
| 臺大學術典藏 |
2020-09-30T03:22:16Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Ou S.-T.; Lin S.-W.; Huang W.-C.;Huang C.-K.;Huang S.-H.;Lin S.-W.;Ou S.-T.;Chen Y.-T.;Chen Y.-W.;Chang S.-Y.;Liu W.-C.;Sun H.-Y.;Chien-Ching Hung; Huang W.-C.; Huang C.-K.; Huang S.-H. |
| 臺大學術典藏 |
2021-08-23T23:47:19Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang W.-C.; Huang C.-K.; Huang S.-H.; Lin S.-W.; Ou S.-T.; YI-TING CHEN; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2020 |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang S.-H.; Lin S.-W.; Huang C.-K.; Huang W.-C.; Hung C.-C.; HSIN-YUN SUN; Liu W.-C.; Chang S.-Y.; Chen Y.-W.; Ou S.-T.; Chen Y.-T. |
| 臺大學術典藏 |
2022-05-05T03:40:07Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang, Wei-Chieh; Huang, Chun-Kai; Huang, Sung-Hsi; Lin, Shu-Wen; Ou, Shyh-Tyan; YI-TING CHEN; Chen, Ya-Wen; Chang, Shu-Yuan; Liu, Wen-Chun; Sun, Hsin-Yun; Hung, Chien-Ching |
| 臺大學術典藏 |
2022-09-07T06:39:07Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang W.-C.; Huang C.-K.; Huang S.-H.; SHU-WEN LIN; Ou S.-T.; Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 中山醫學大學 |
2020 |
Therapeutic Duplication in Taiwan Hospitals for Patients With High Blood Pressure, Sugar, and Lipids: Evaluation With a Mobile Health Mapping Tool
|
Kan, WC; Kuo, SC; Chien, TW; Lin, JCJ; Yeh, YT; Chou, W; Chou, PH |
| 國立成功大學 |
2018 |
Therapeutic Duplication of Long-Acting Injectable Drugs
|
Shao, Shao S.-C.;Lai, E.C.-C.;Chan, Y.-Y.;Hung, M.-J.;Chen, H.-Y. |
顯示項目 871661-871670 / 2348719 (共234872頁)
<< < 87162 87163 87164 87165 87166 87167 87168 87169 87170 87171 > >>
每頁顯示[10|25|50]項目
|
